Asia-pacific Cartilage Degeneration Market Forecast 2021-2028

Asia-pacific Cartilage Degeneration Market Forecast 2021-2028


The Asia-Pacific cartilage degeneration market is projected to record a CAGR of 4.87% during the estimated period of 2021 to 2028. Factors like the significant surge in the geriatric population, the growing acceptance of sports across the younger generation, and the increasing expenditure on public health care systems are anticipated to play a pivotal role in fueling the regional market’s growth.


The Asia-Pacific cartilage degeneration market growth assessment comprises a detailed analysis of Singapore, South Korea, India, China, Australia & New Zealand, Thailand, Japan, Indonesia, and the rest of the Asia-Pacific. India holds a substantial position across the global cartilage degeneration market on account of the increased focus on cartilage science in the country. For instance, the foundation of the Indian Cartilage Society aims to raise awareness regarding cartilage science. In addition, it also strives to augment the economic infrastructure for autologous chondrocyte implantation since India has an ideal number of resources and intellectuals.

On the other hand, South Korea’s medical technology sector is the fourth largest across the Asia-Pacific, providing the market with lucrative growth opportunities. The nation also has the presence of numerous countries operating worldwide, in addition to establishing an international brand. South Korea possesses some of the best healthcare facilities, thereby delivering world-class healthcare to medical tourists as well as its citizens. Therefore, these factors are set to propel the Asia-Pacific cartilage degeneration market growth over the forecasting years.


Some of the top firms operating in the market are Stryker Corporation, B. Braun Melsungen AG, Johnson & Johnson, Smith & Nephew, etc.

Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Sports Injuries Damaging Cartilage And Ligaments
3.1.2. Degeneration Of Cartilage Due To Obesity
3.1.3. Bone And Joint-related Diseases In The Geriatric Population
3.2. Key Restraints
3.2.1. High Cost Of Cartilage Repair Therapies
4. Key Analytics
4.1. Impact Of Covid-19 On Cartilage Degeneration Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Threat Of New Entry
4.3.2. Threat Of Substitution
4.3.3. Buyers Power
4.3.4. Suppliers Power
4.3.5. Competitive Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
5. Market By Procedure
5.1. Joint Replacement
5.2. Chondroplasty
5.3. Cell-based Cartilage Resurfacing
5.4. Osteochondral Transplant
5.5. Meniscus Transplants
5.6. Other Procedures
6. Market By Application
6.1. Knee
6.2. Hips
6.3. Other Applications
7. Market By End-user
7.1. Ambulatory Surgical Centers
7.2. Hospitals & Specialty Clinics
7.3. Academic & Research Institutes
8. Geographical Analysis
8.1. Asia-pacific
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis China Japan Australia & New Zealand India South Korea Thailand Singapore Indonesia Rest Of Asia-pacific
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions, Announcements, And Divestitures
9.2. Company Profiles
9.2.1. Anika Therapeutics Inc
9.2.2. Arthrex Inc
9.2.3. B Braun Melsungen Ag
9.2.4. Biotissue Sa
9.2.5. Cartiheal Inc
9.2.6. Conmed Corporation
9.2.7. Depuy Synthes Companies
9.2.8. Osiris Therapeutics Inc
9.2.9. Rti Surgical Inc
9.2.10. Smith & Nephew Plc
9.2.11. Stryker Corporation
9.2.12. Vericel Corporation
9.2.13. Zimmer Biomet Holdings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings